|
Volumn 20, Issue 4, 2001, Pages 239-244
|
Malignancy in Behçet's disease: A report of 13 cases and a review of the literature
a a a a a a |
Author keywords
Beh et's disease; Cancer; Late morbidity; Radiotherapy; Surgery
|
Indexed keywords
BENZATHINE PENICILLIN;
BLEOMYCIN;
CHLORAMBUCIL;
CISPLATIN;
COLCHICINE;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
FOLIC ACID;
IFOSFAMIDE;
IMMUNOSUPPRESSIVE AGENT;
INDOMETACIN;
INTERFERON;
MESNA;
MITOXANTRONE;
PREDNISOLONE;
THALIDOMIDE;
VINBLASTINE;
ADULT;
AUTOIMMUNE DISEASE;
BEHCET DISEASE;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
FEMALE;
FOLLOW UP;
HEMATOLOGIC DISEASE;
HUMAN;
LYMPHOMA;
MALE;
MALIGNANT NEOPLASTIC DISEASE;
MALIGNANT TRANSFORMATION;
MEDICAL LITERATURE;
MORBIDITY;
PRIORITY JOURNAL;
REVIEW;
SOLID TUMOR;
TOXICITY;
TURKEY (REPUBLIC);
UNIVERSITY HOSPITAL;
WOUND INFECTION;
ADULT;
BEHCET SYNDROME;
COMBINED MODALITY THERAPY;
COMORBIDITY;
FEMALE;
HUMANS;
LYMPHOMA;
MALE;
MIDDLE AGED;
NEOPLASMS;
PREVALENCE;
PROGNOSIS;
RISK ASSESSMENT;
SURVIVAL RATE;
|
EID: 0034891665
PISSN: 07703198
EISSN: None
Source Type: Journal
DOI: 10.1007/s100670170036 Document Type: Review |
Times cited : (54)
|
References (52)
|